About Osagie Imasogie
Form D filings for Biopharmaceutical Research in 2023 list Osagie Imasogie as director.
Osagie Imasogie first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Osagie Imasogie in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Osagie Imasogie works with at each company, as listed on that company's latest Form D.
Biopharmaceutical Research Co · Form D, Aug 9, 2023
CS
Charles Schumacher
Director
DW
David Weinmann
Executive officer
GH
George Hodgin
Chief Executive Officer and director